Sustainability and Environment, Social and Governance (ESG) Overview

The report presents ANGLE's liquid-biopsy technology as supporting cancer diagnosis and monitoring while reducing travel and healthcare-resource use. It identifies ten priority SDGs, including Goals 3, 4, 5, 8, 9, 10, 11, 12, 14 and 16. The company reports 120 permanent staff at year end, 56% female staff and 100% renewable energy. It also highlights ISO 13485 quality management, six science placements, two apprenticeships and community partnerships including Cancer Research UK.